Lymphangioleiomyomatosis (LAM)

Source: Breathe 2017; 13: 64-71
Journal Issue: March

Full text journal articlePDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lymphangioleiomyomatosis (LAM). Breathe 2017; 13: 64-71

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Source: Eur Respir J 2006; 28: 1284
Year: 2006

Source: Eur Respir Mon; 2009: 46: 176–207
Year: 2009

Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008

LAM: lymphangioleiomyomatosis
Source: Breathe 2014; 10:331-332
Year: 2014

Lymphangioleiomyomatosis (LAM) initially presented as retroperitoneal tumour. Two case reports
Source: Eur Respir J 2005; 26: Suppl. 49, 83s
Year: 2005

Lymphangioleiomyomatosis – an analysis of 4 cases
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007

Is pulmonary rehabilitation (PR) an effective therapy in lymphangioleiomyomatosis (LAM)?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012

Lymphangioleiomyomatosis: what do we know and what are we looking for?
Source: Eur Respir Rev 2011; 20: 34-44
Year: 2011

Lymphangioleiomyomatosis: characteristics of 96 patients in China
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Lymphangioleiomyomatosis: a clinical review
Source: Breathe, 16 (2) 200007; 10.1183/20734735.0007-2020
Year: 2020

Experience with lung transplantation in lymphangioleiomyomatosis (LAM) in our center
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Serial CT density in lymphangioleiomyomatosis (LAM)
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL)
Source: Eur Respir J 2004; 24: Suppl. 48, 222s
Year: 2004

Ten-years follow-up of slowly progressive pulmonary lymphangioleiomyomatosis (PLAM)
Source: Eur Respir J 2001; 18: Suppl. 33, 219s
Year: 2001

Case report: Hermansky-Pudlak syndrome (HPS) and single lung transplantation (LUTX)
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

Early-onset therapy with sirolimus helps to improve prognosis of patients with lymphangioleiomyomatosis (LAM)
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019

Source: Eur Respir J 2006; 27: 1056-1065
Year: 2006

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
Source: ERJ Open Res, 4 (1) 00121-2017; 10.1183/23120541.00121-2017
Year: 2018

Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM)
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013